To subscribe to our monthly email newsletter, please send an email to newsletter@jlewisresearch.com with "Subscribe" in the…
J. Lewis Research, Inc.September 3, 2013
To subscribe to our monthly email newsletter, please send an email to newsletter@jlewisresearch.com with "Subscribe" in the…
J. Lewis Research, Inc.August 2, 2013
Click here for info about the 2015 expo Come see us at the KUTV 2…
J. Lewis Research, Inc.July 5, 2013
To subscribe to our monthly email newsletter, please send an email to newsletter@jlewisresearch.com with "Subscribe" in the…
J. Lewis Research, Inc.July 1, 2013
Clinical trials are a necessary part of the drug development process. They help to assure…
J. Lewis Research, Inc.June 24, 2013
Last week the FDA approved two drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with…
J. Lewis Research, Inc.June 7, 2013
To subscribe to our monthly email newsletter, please send an email to newsletter@jlewisresearch.com with "Subscribe"…
J. Lewis Research, Inc.May 31, 2013
GlaxoSmithKline (GSK) will join Save the Children in order to fight the leading causes of…
J. Lewis Research, Inc.May 10, 2013
It is often difficult to enroll patients in clinical trials, a problem that is seen…
J. Lewis Research, Inc.May 7, 2013
